References
- Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. Cancer 1969; 23: 198–202
- Kemeny N, Daly J, Oderman P, et al. Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. I Clin Oncol 1984; 2: 595–600
- Hohn Melniclc D. J., Stagg R, et al. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol 1985; 3: 98–102
- Stagg R, Lewis B, Friedman M, et al. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann Intern Med 1984; 100: 736–743
- Weiss G, Gamick M, Osten R, et al. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. J Clin Oncol 1983; 1: 337–344
- Niederhuber J, Ensminger W, Gyves J, et al. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 1984; 53: 1336–1343
- Huberman M. Comparison of systemic chemotherapy with hepatic arterial infusion in metastic colorectal carcinoma. Semin Oncol 1983; 10: 238–248
- Daly J, Kemeny N, Oderman P, et al. Long-term hepatic arterial infusion chemotherapy. Arch Surg 1984; 119: 936–941
- Johnson L, Rivkin S. The implanted pump in metastatic colorectal cancer of the liver. Am J Surg 1985; 149: 595–598
- Balch C, Urist M, McGregor M. Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. Am J Surg 1983; 145: 285–290
- Wands J, Koff R, Isselbacher K. Chronic active hepatitis. Harrison's Principles of Internal Medicine, ed. 10, R Petersdorf, R Adams, E Braunwald, et al. McGraw-Hill, New York 1983